Evidence map›Paper›PMID 33465134›Full record

ArticlePLoS pathogens2021

T-bet-dependent ILC1- and NK cell-derived IFN-γ mediates cDC1-dependent host resistance against Toxoplasma gondii.

Américo H López-Yglesias, Elise Burger, Ellie Camanzo, Andrew T Martin, Alessandra M Araujo, Samantha F Kwok, Felix Yarovinsky

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Dysregulated immunometabolism in gut inflammation.Acta biochimica et biophysica Sinica · 2026
    Review
  6. Lymphotoxin beta receptorInfection and immunity · 2025
    Article
  7. Review
  8. Review
  9. Regulation of innate lymphoid cell by microbial metabolites.Journal of molecular medicine (Berlin, Germany) · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Américo H López-YglesiasCenter for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.ORCID 0000-0001-6797-2179
Elise BurgerCenter for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.ORCID 0000-0002-4309-7725
Ellie CamanzoCenter for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.ORCID 0000-0002-0151-077X
Andrew T MartinCenter for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.ORCID 0000-0002-5790-3054
Alessandra M AraujoCenter for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.ORCID 0000-0001-7568-074X
Samantha F KwokCenter for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.
Felix YarovinskyCenter for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, United States of America.ORCID 0000-0001-5825-8002
University of Rochester · US

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
The T32 Predoctoral Training Program in Immunology (PTPI)T32AI007285 · NIAID · UNIVERSITY OF ROCHESTER · PI Scott Andrew Gerber, JACQUES Robert · 1986 to 2026
$7.6M
INTEGRATIVE IMMUNOLOGY TRAINING PROGRAMT32AI005284 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Nan Yan · 2003 to 2026
$7.4M
Mucosal immunity to Toxoplasma gondiiR01AI136538 · NIAID · UNIVERSITY OF ROCHESTER · PI Felix Yarovinsky · 2018 to 2026
$4.0M
Neutrophil IFN-gamma in host defense and inflammationR01AI121090 · NIAID · UNIVERSITY OF ROCHESTER · PI YAROVINSKY, FELIX · 2016 to 2020
$2.3M
Myeloid innate immune T-bet functions in host defense to Toxoplasma gondiiF32AI138414 · NIAID · UNIVERSITY OF ROCHESTER · PI LOPEZ-YGLESIAS, AMERICO HARRY · 2018 to 2019
$104k
NIAID NIH HHS F32 AI138414NIAID NIH HHS R01 AI121090NIAID NIH HHS R01 AI136538NIAID NIH HHS T32 AI005284NIAID NIH HHS T32 AI007140NIAID NIH HHS T32 AI007285
6 · The paper itself

Abstract

Host resistance against intracellular pathogens requires a rapid IFN-γ mediated immune response. We reveal that T-bet-dependent production of IFN-γ is essential for the maintenance of inflammatory DCs at the site of infection with a common protozoan parasite, Toxoplasma gondii. A detailed analysis of the cellular sources for T-bet-dependent IFN-γ identified that ILC1s and to a lesser degree NK, but not TH1 cells, were involved in the regulation of inflammatory DCs via IFN-γ. Mechanistically, we established that T-bet dependent innate IFN-γ is critical for the induction of IRF8, an essential transcription factor for cDC1s. Failure to upregulate IRF8 in DCs resulted in acute susceptibility to T. gondii infection. Our data identifies that T-bet dependent production of IFN-γ by ILC1 and NK cells is indispensable for host resistance against intracellular infection via maintaining IRF8+ inflammatory DCs at the site of infection.

Indexed as

AnimalsDendritic CellsFemaleImmunity, InnateInterferon-gammaInterferon Regulatory Factor-8Interferon Regulatory FactorsKiller Cells, NaturalLymphocytesMaleMiceMice, Inbred C57BLMice, KnockoutT-bet Transcription FactorT-Box Domain ProteinsToxoplasmaInterferon-gammaInterferon Regulatory Factor-8Interferon Regulatory FactorsT-bet Transcription FactorT-Box Domain Proteins

Identifiers

PMID33465134
PMCPMC7875365
OpenAlexW3125443858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.